BRIEF- Celgene invests $6 mln in Alliqua at $3.59/shr

Tue Nov 19, 2013 7:36am EST

Nov 19 (Reuters) - Alliqua Inc : * Announces transaction with Celgene * Says Celgene invests $6.0 million in Alliqua at $3.59 per share * Says Alliqua receives license to Celgene cellular therapeutics advanced wound

care products * In connection with agreement to invest in alliqua's securities, Celgene

received right to appoint a director to alliqua's board of directors * Says several unrelated funds led by broadfin capital & perceptive advisors

invested an additional $7 million on comparable financial terms * Source text for Eikon * Further company coverage

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.